Stockscreener 앱 받기
6.90
2.13%
-0.15
시간 외 거래:
6.90
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
IGM Biosciences, Inc. (NASDAQ:IGMS) CEO Mary Beth Harler Sells 1,708 Shares - MarketBeat
Igm biosciences principal accounting officer sells shares for $4,031 - Investing.com
Igm biosciences CEO sells $12,775 in stock - Investing.com
IGM Biosciences chief business officer sells shares worth $7,951 By Investing.com - Investing.com Canada
IGM Biosciences (NASDAQ:IGMS shareholders incur further losses as stock declines 21% this week, taking five-year losses to 84% - Simply Wall St
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Target Price at $17.75 - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $17.75 Average Target Price from Analysts - MarketBeat
IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism - Investing.com Australia
IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism By Investing.com - Investing.com South Africa
BMO Capital Markets Begins Coverage on IGM Biosciences (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Gap Up – Here’s What Happened - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Gap UpStill a Buy? - MarketBeat
BMO Capital Initiates Coverage of IGM Biosciences (IGMS) with Outperform Recommendation - MSN
IGM Biosciences (NASDAQ:IGMS) Coverage Initiated by Analysts at BMO Capital Markets - MarketBeat
BMO sets $21 target for IGM Biosciences with Outperform rating By Investing.com - Investing.com UK
IGM Biosciences: Dizzying Number Of Pivots (NASDAQ:IGMS) - Seeking Alpha
Quest Partners LLC Decreases Stock Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Down 4.1%Should You Sell? - MarketBeat
How to Take Advantage of moves in (IGMS) - Stock Traders Daily
IGM Biosciences (NASDAQ:IGMS) Shares Gap DownHere's What Happened - MarketBeat
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Price Target at $16.13 - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Will Imvotamab Data Propel IGM Biosciences To New Heights In 2025? - RTTNews
How To Trade (IGMS) - Stock Traders Daily
FMR LLC Increases Stake in IGM Biosciences Inc - GuruFocus.com
IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip - Simply Wall St
Biotech firm backs off its focus on oncology research - The Business Journals
IGM Biosciences (NASDAQ:IGMS) Given New $27.00 Price Target at Stifel Nicolaus - MarketBeat
Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development - MSN
IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
IGM Biosciences (NASDAQ:IGMS) Shares Down 7.8%Here's Why - MarketBeat
IGM Biosciences Inc (IGMS) Quarterly 10-Q Report - Quartz
IGM Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
IGM Biosciences earnings missed by $0.21, revenue topped estimates - Investing.com UK
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
IGM Biosciences Reports $61.4M Loss, Extends Cash Runway to 2027 Despite Clinical Progress | IGMS Stock News - StockTitan
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewswire
(IGMS) Investment Report - Stock Traders Daily
IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7%Should You Sell? - MarketBeat
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $15.00 - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading 7.7% HigherHere's Why - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook - Investing.com India
2.88%
2.65%
자본화:
|
볼륨(24시간):